HEADER HYDROLASE 03-NOV-20 7AUX TITLE CRYSTAL STRUCTURE OF OXA-48 BETA-LACTAMASE IN THE COMPLEX WITH THE TITLE 2 INHBITOR ID2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.5.2.6; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: THE LYSIN 73 IS CARBOXYLATED (KCX) SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: KLEBSIELLA PNEUMONIAE; SOURCE 3 ORGANISM_TAXID: 573; SOURCE 4 GENE: BLA OXA-48, BLAOXA-48, KPE71T_00045; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS CLASS D BETA-LACTAMASE, OXA-48, ANTIBIOTIC, DIMER, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR G.POCHETTI,R.MONTANARI,D.CAPELLI,B.GAROFALO,R.OMBRATO REVDAT 2 31-JAN-24 7AUX 1 REMARK REVDAT 1 21-JUL-21 7AUX 0 JRNL AUTH B.GAROFALO,F.PRATI,R.BUONFIGLIO,I.COLETTA,N.D'ATANASIO, JRNL AUTH 2 A.MOLTENI,D.CARETTONI,V.WANKE,G.POCHETTI,R.MONTANARI, JRNL AUTH 3 D.CAPELLI,C.MILANESE,F.P.DI GIORGIO,R.OMBRATO JRNL TITL DISCOVERY OF NOVEL CHEMICAL SERIES OF OXA-48 BETA-LACTAMASE JRNL TITL 2 INHIBITORS BY HIGH-THROUGHPUT SCREENING. JRNL REF PHARMACEUTICALS V. 14 2021 JRNL REFN ESSN 1424-8247 JRNL PMID 34202402 JRNL DOI 10.3390/PH14070612 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 62.88 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 40770 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.930 REMARK 3 FREE R VALUE TEST SET COUNT : 2010 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 10.0000 - 4.9401 0.98 2980 157 0.1688 0.2198 REMARK 3 2 4.9401 - 3.9213 0.98 2820 146 0.1592 0.1645 REMARK 3 3 3.9213 - 3.4256 0.99 2840 148 0.1793 0.2032 REMARK 3 4 3.4256 - 3.1124 0.98 2775 149 0.2006 0.2602 REMARK 3 5 3.1124 - 2.8894 0.98 2762 140 0.2182 0.2734 REMARK 3 6 2.8894 - 2.7190 0.99 2817 139 0.2304 0.2983 REMARK 3 7 2.7190 - 2.5828 0.98 2734 146 0.2335 0.2459 REMARK 3 8 2.5828 - 2.4704 0.98 2759 142 0.2370 0.3341 REMARK 3 9 2.4704 - 2.3753 0.95 2641 140 0.2466 0.3119 REMARK 3 10 2.3753 - 2.2933 0.97 2736 142 0.2540 0.2970 REMARK 3 11 2.2933 - 2.2216 0.97 2724 143 0.2628 0.3171 REMARK 3 12 2.2216 - 2.1581 0.98 2706 135 0.2650 0.2793 REMARK 3 13 2.1581 - 2.1013 0.98 2738 140 0.2684 0.3321 REMARK 3 14 2.1013 - 2.0500 0.98 2728 143 0.2962 0.3122 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.410 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4122 REMARK 3 ANGLE : 1.147 5584 REMARK 3 CHIRALITY : 0.042 578 REMARK 3 PLANARITY : 0.005 716 REMARK 3 DIHEDRAL : 15.234 1516 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7AUX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-NOV-20. REMARK 100 THE DEPOSITION ID IS D_1292112134. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-FEB-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.072 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40846 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 62.882 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.76200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 3HBR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES, PH 7.5, 12% PEG8000, 8% 1 REMARK 280 -BUTANOL, OXA-48 8.0-8.5 MG/ML, INHIBITOR/PROTEIN 6.5:1, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.70500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.83000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.31500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.83000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.70500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.31500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMER REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMER REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 69 -138.54 49.35 REMARK 500 SER A 155 10.84 -156.49 REMARK 500 ASP A 159 10.76 -142.95 REMARK 500 ASN A 200 -168.10 -160.50 REMARK 500 GLN B 52 53.16 32.36 REMARK 500 ALA B 69 -138.70 47.43 REMARK 500 GLU B 147 12.60 53.43 REMARK 500 SER B 155 10.68 -163.30 REMARK 500 ASP B 159 22.23 -147.99 REMARK 500 REMARK 500 REMARK: NULL DBREF 7AUX A 24 265 UNP Q6XEC0 Q6XEC0_KLEPN 24 265 DBREF 7AUX B 24 265 UNP Q6XEC0 Q6XEC0_KLEPN 24 265 SEQRES 1 A 242 GLU TRP GLN GLU ASN LYS SER TRP ASN ALA HIS PHE THR SEQRES 2 A 242 GLU HIS LYS SER GLN GLY VAL VAL VAL LEU TRP ASN GLU SEQRES 3 A 242 ASN LYS GLN GLN GLY PHE THR ASN ASN LEU LYS ARG ALA SEQRES 4 A 242 ASN GLN ALA PHE LEU PRO ALA SER THR PHE KCX ILE PRO SEQRES 5 A 242 ASN SER LEU ILE ALA LEU ASP LEU GLY VAL VAL LYS ASP SEQRES 6 A 242 GLU HIS GLN VAL PHE LYS TRP ASP GLY GLN THR ARG ASP SEQRES 7 A 242 ILE ALA THR TRP ASN ARG ASP HIS ASN LEU ILE THR ALA SEQRES 8 A 242 MET LYS TYR SER VAL VAL PRO VAL TYR GLN GLU PHE ALA SEQRES 9 A 242 ARG GLN ILE GLY GLU ALA ARG MET SER LYS MET LEU HIS SEQRES 10 A 242 ALA PHE ASP TYR GLY ASN GLU ASP ILE SER GLY ASN VAL SEQRES 11 A 242 ASP SER PHE TRP LEU ASP GLY GLY ILE ARG ILE SER ALA SEQRES 12 A 242 THR GLU GLN ILE SER PHE LEU ARG LYS LEU TYR HIS ASN SEQRES 13 A 242 LYS LEU HIS VAL SER GLU ARG SER GLN ARG ILE VAL LYS SEQRES 14 A 242 GLN ALA MET LEU THR GLU ALA ASN GLY ASP TYR ILE ILE SEQRES 15 A 242 ARG ALA LYS THR GLY TYR SER THR ARG ILE GLU PRO LYS SEQRES 16 A 242 ILE GLY TRP TRP VAL GLY TRP VAL GLU LEU ASP ASP ASN SEQRES 17 A 242 VAL TRP PHE PHE ALA MET ASN MET ASP MET PRO THR SER SEQRES 18 A 242 ASP GLY LEU GLY LEU ARG GLN ALA ILE THR LYS GLU VAL SEQRES 19 A 242 LEU LYS GLN GLU LYS ILE ILE PRO SEQRES 1 B 242 GLU TRP GLN GLU ASN LYS SER TRP ASN ALA HIS PHE THR SEQRES 2 B 242 GLU HIS LYS SER GLN GLY VAL VAL VAL LEU TRP ASN GLU SEQRES 3 B 242 ASN LYS GLN GLN GLY PHE THR ASN ASN LEU LYS ARG ALA SEQRES 4 B 242 ASN GLN ALA PHE LEU PRO ALA SER THR PHE KCX ILE PRO SEQRES 5 B 242 ASN SER LEU ILE ALA LEU ASP LEU GLY VAL VAL LYS ASP SEQRES 6 B 242 GLU HIS GLN VAL PHE LYS TRP ASP GLY GLN THR ARG ASP SEQRES 7 B 242 ILE ALA THR TRP ASN ARG ASP HIS ASN LEU ILE THR ALA SEQRES 8 B 242 MET LYS TYR SER VAL VAL PRO VAL TYR GLN GLU PHE ALA SEQRES 9 B 242 ARG GLN ILE GLY GLU ALA ARG MET SER LYS MET LEU HIS SEQRES 10 B 242 ALA PHE ASP TYR GLY ASN GLU ASP ILE SER GLY ASN VAL SEQRES 11 B 242 ASP SER PHE TRP LEU ASP GLY GLY ILE ARG ILE SER ALA SEQRES 12 B 242 THR GLU GLN ILE SER PHE LEU ARG LYS LEU TYR HIS ASN SEQRES 13 B 242 LYS LEU HIS VAL SER GLU ARG SER GLN ARG ILE VAL LYS SEQRES 14 B 242 GLN ALA MET LEU THR GLU ALA ASN GLY ASP TYR ILE ILE SEQRES 15 B 242 ARG ALA LYS THR GLY TYR SER THR ARG ILE GLU PRO LYS SEQRES 16 B 242 ILE GLY TRP TRP VAL GLY TRP VAL GLU LEU ASP ASP ASN SEQRES 17 B 242 VAL TRP PHE PHE ALA MET ASN MET ASP MET PRO THR SER SEQRES 18 B 242 ASP GLY LEU GLY LEU ARG GLN ALA ILE THR LYS GLU VAL SEQRES 19 B 242 LEU LYS GLN GLU LYS ILE ILE PRO MODRES 7AUX KCX A 73 LYS MODIFIED RESIDUE MODRES 7AUX KCX B 73 LYS MODIFIED RESIDUE HET KCX A 73 12 HET KCX B 73 12 HET CL A 301 1 HET LKW A 302 29 HET LKW B 301 29 HETNAM KCX LYSINE NZ-CARBOXYLIC ACID HETNAM CL CHLORIDE ION HETNAM LKW 6-(4-CARBOXYPHENYL)-3-(4-ETHYLPHENYL)-2~{H}-PYRAZOLO[3, HETNAM 2 LKW 4-B]PYRIDINE-4-CARBOXYLIC ACID FORMUL 1 KCX 2(C7 H14 N2 O4) FORMUL 3 CL CL 1- FORMUL 4 LKW 2(C22 H17 N3 O4) FORMUL 6 HOH *245(H2 O) HELIX 1 AA1 TRP A 31 GLU A 37 1 7 HELIX 2 AA2 ASN A 58 ASN A 63 1 6 HELIX 3 AA3 PRO A 68 THR A 71 5 4 HELIX 4 AA4 PHE A 72 GLY A 84 1 13 HELIX 5 AA5 ILE A 102 ASN A 106 5 5 HELIX 6 AA6 ASN A 110 TYR A 117 1 8 HELIX 7 AA7 VAL A 119 ASP A 143 1 25 HELIX 8 AA8 SER A 155 GLY A 160 1 6 HELIX 9 AA9 ALA A 166 HIS A 178 1 13 HELIX 10 AB1 SER A 184 MET A 195 1 12 HELIX 11 AB2 THR A 243 LEU A 247 5 5 HELIX 12 AB3 GLY A 248 GLU A 261 1 14 HELIX 13 AB4 TRP B 31 GLU B 37 1 7 HELIX 14 AB5 ASN B 58 ASN B 63 1 6 HELIX 15 AB6 PRO B 68 THR B 71 5 4 HELIX 16 AB7 PHE B 72 GLY B 84 1 13 HELIX 17 AB8 ILE B 102 ASN B 106 5 5 HELIX 18 AB9 ASN B 110 SER B 118 1 9 HELIX 19 AC1 VAL B 119 ASP B 143 1 25 HELIX 20 AC2 SER B 155 GLY B 160 1 6 HELIX 21 AC3 ALA B 166 HIS B 178 1 13 HELIX 22 AC4 SER B 184 MET B 195 1 12 HELIX 23 AC5 THR B 243 LEU B 247 5 5 HELIX 24 AC6 GLY B 248 GLU B 261 1 14 SHEET 1 AA1 7 TRP A 25 GLU A 27 0 SHEET 2 AA1 7 GLN A 53 THR A 56 1 O GLY A 54 N GLN A 26 SHEET 3 AA1 7 GLY A 42 ASN A 48 -1 N LEU A 46 O PHE A 55 SHEET 4 AA1 7 VAL A 232 ASP A 240 -1 O ASN A 238 N VAL A 43 SHEET 5 AA1 7 ILE A 219 GLU A 227 -1 N VAL A 226 O TRP A 233 SHEET 6 AA1 7 ILE A 204 SER A 212 -1 N ILE A 204 O GLU A 227 SHEET 7 AA1 7 LEU A 196 ALA A 199 -1 N GLU A 198 O ILE A 205 SHEET 1 AA2 2 ALA A 65 PHE A 66 0 SHEET 2 AA2 2 ILE A 164 SER A 165 -1 O ILE A 164 N PHE A 66 SHEET 1 AA3 7 TRP B 25 GLU B 27 0 SHEET 2 AA3 7 GLN B 53 THR B 56 1 O THR B 56 N GLN B 26 SHEET 3 AA3 7 GLY B 42 ASN B 48 -1 N ASN B 48 O GLN B 53 SHEET 4 AA3 7 VAL B 232 ASP B 240 -1 O ASN B 238 N VAL B 43 SHEET 5 AA3 7 ILE B 219 GLU B 227 -1 N GLY B 224 O PHE B 235 SHEET 6 AA3 7 ILE B 204 SER B 212 -1 N ILE B 204 O GLU B 227 SHEET 7 AA3 7 LEU B 196 ALA B 199 -1 N GLU B 198 O ILE B 205 SHEET 1 AA4 2 ALA B 65 PHE B 66 0 SHEET 2 AA4 2 ILE B 164 SER B 165 -1 O ILE B 164 N PHE B 66 LINK C PHE A 72 N KCX A 73 1555 1555 1.32 LINK C KCX A 73 N ILE A 74 1555 1555 1.31 LINK C PHE B 72 N KCX B 73 1555 1555 1.32 LINK C KCX B 73 N ILE B 74 1555 1555 1.32 CISPEP 1 GLU A 216 PRO A 217 0 -6.44 CISPEP 2 GLU B 216 PRO B 217 0 -6.28 CRYST1 71.410 72.630 125.660 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014004 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013768 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007958 0.00000